SOURCE: Implant Sciences

Implant Sciences

April 25, 2011 07:07 ET

Implant Sciences Signs New Distributors in Canada and Brazil

Two of the Largest Security Markets in the World

WILMINGTON, MA--(Marketwire - Apr 25, 2011) - Continuing the rapid build-out of its global sales and distribution channels, Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced the addition of distributors in two of the Americas' largest markets, Canada and Brazil. Military and defense spending in 2010 were an estimated $20 billion in Canada and $28 billion in Brazil.

In Canada, Implant Sciences has signed R. Nicholls Distributors, Inc., which has served the Canadian military and law enforcement markets for 30 years. R. Nicholls is a leading provider of over 50 products, with a staff of approximately 200, and annual sales of over CAD$50 million. The company is a member of numerous organizations including the Canadian Defense Industry Association.

Implant Sciences has also signed a distribution agreement in Brazil with Ormax Technologia en Seguranca, a division of Intelabs Technologies, a large industrial group that has been focused in security equipment manufacture and sales for 20 years to customers in government and private industry. Ormax is one of the leading companies in the security market, manufacturing and distributing a diversified line of products in access control, police intelligence, night vision and other security applications. Ormax has a network providing technical support, marketing and after-sales service.

"Our participation in a key trade mission to Brazil in 2010 was a step towards establishing strong distribution channels there. Combined with Canada, the two markets have an aggregate of $48 billion annually in military and defense spending. As our revenues continue to grow, we are already reaping the benefits of focusing on building our channel partners, and our market presence is increasing worldwide," stated Implant Sciences CEO, Glenn Bolduc.

About the Quantum Sniffer QS-H150

The QS-H150 Quantum Sniffer is a hand-held explosive trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, and homemade explosives. The QS-H150 features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 Portable Explosives Detector has been designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by governments or by other law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:

    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    CEO
    978-752-1700
    Email Contact

    or

    Investor Contact:
    Laurel Moody
    646-810-0608
    Email Contact